Development of North American consensus guidelines for medical laboratories that perform and interpret platelet function testing using light transmission aggregometry

American Journal of Clinical Pathology

Volumn 134, Issue 6, 2010, Pages 955-963

  Hayward, Catherine P M ^a,b,c   Moffat, Karen A ^a,b,c   Raby, Anne ^d   Israels, Sara ^a,e   Plumhoff, Elizabeth ^a,f   Flynn, Greg ^d   Zehnder, James L ^a,g  

^a North American Specialized Coagulation Laboratory Association   (United States)

^b HAMILTON REGIONAL LABORATORY MEDICINE PROGRAM   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d Quality Management Program   (Canada)

^e UNIVERSITY OF MANITOBA   (Canada)

^f MAYO CLINIC   (United States)

^g STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acquired platelet disorders; Bleeding time; Inherited platelet disorders; Light transmission aggregometry; Platelet aggregation; Platelet function

Indexed keywords

ARTICLE; BLOOD CLOTTING TEST; CONSENSUS DEVELOPMENT; GOOD LABORATORY PRACTICE; HEALTH CARE QUALITY; LIGHT TRANSMISSION AGGREGOMETRY; NORTH AMERICA; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY CONTROL; STATISTICAL ANALYSIS; THROMBOCYTE FUNCTION;

BLOOD PLATELET DISORDERS; CLINICAL LABORATORY TECHNIQUES; HUMANS; LABORATORIES, HOSPITAL; NORTH AMERICA; PLATELET AGGREGATION; PLATELET FUNCTION TESTS; REFERENCE VALUES;

EID: 78649643870     PISSN: 00029173     EISSN: 19437722     Source Type: Journal    
DOI: 10.1309/AJCP9V3RRVNZMKDS     Document Type: Article

References (26)

1. Hayward CP, Rao AK, Cattaneo M. Congenital platelet disorders: overview of their mechanisms, diagnostic evaluation and treatment. Haemophilia. 2006;12(suppl 3):128-136.
2. Nurden P, Nurden AT. Congenital disorders associated with platelet dysfunctions. Thromb Haemost. 2008;99:253-263. (Pubitemid 351230953)
3. Nurden AT, Nurden P. Inherited disorders of platelets: an update. Curr Opin Hematol. 2006;13:157-162.
4. Israels SJ. Diagnostic evaluation of platelet function disorders in neonates and children: an update. Semin Thromb Hemost. 2009;35:181-188.
5. Cattaneo M. Light transmission aggregometry and ATP release for the diagnostic assessment of platelet function. Semin Thromb Hemost. 2009;35:158-167.
6. Hayward CP, Harrison P, Cattaneo M, et al. Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function. J Thromb Haemost. 2006;4:312-319.
7. Michelson AD, Cattaneo M, Eikelboom JW, et al. Aspirin resistance: position paper of the Working Group on Aspirin Resistance. J Thromb Haemost. 2005;3:1309-1311.
8. Christie DJ, Avari T, Carrington LR, et al. Platelet Function Testing by Aggregometry; Approved guideline. CLSI document H58-A; Vol 38; No. 31. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
9. Guidelines on platelet function testing: The British Society for Haematology BCSH Haemostasis and Thrombosis Task Force. J Clin Pathol. 1988;41:1322-1330.
10. Moffat KA, Ledford-Kraemer MR, Nichols WL, et al. Variability in clinical laboratory practice in testing for disorders of platelet function: results of two surveys of the North American Specialized Coagulation Laboratory Association. Thromb Haemost. 2005;93:549-553.
11. Cattaneo M, Hayward CP, Moffat KA, et al. Results of a worldwide survey on the assessment of platelet function by light transmission aggregometry: a report from the Platelet Physiology Subcommittee of the SSC of the ISTH. J Thromb Haemost. 2009;7:1029.
12. Duncan EM, Bonar R, Rodgers SE, et al. Methodology and outcomes of platelet aggregation testing in Australia, New Zealand and the Asia-Pacific region: results of a survey from the Royal College of Pathologists of Australasia Haematology Quality Assurance Program. Int J Lab Hematol. 2009;31:398-406.
13. Jennings I, Woods TA, Kitchen S, et al. Platelet function testing: practice among UK National External Quality Assessment Scheme for Blood Coagulation participants, 2006. J Clin Pathol. 2008;61:950-954.
14. Pai M, Hayward CP. Diagnostic assessment of platelet disorders: what are the challenges to standardization? Semin Thromb Hemost. 2009;35:131-138.
15. Hayward CP, Pai M, Liu Y, et al. Diagnostic utility of light transmission platelet aggregometry: results from a prospective study of individuals referred for bleeding disorder assessments. J Thromb Haemost. 2009;7:676-684.
16. Hayward CP, Moffat KA, Pai M, et al. An evaluation of methods for determining reference intervals for light transmission platelet aggregation tests on samples with normal or reduced platelet counts. Thromb Haemost. 2008;100:134-145.
17. Quality Management Program-Laboratory Services. Coagulation Committee Comments - COAG-0902-Q [database on the Internet]. Toronto (ON). QMP-LS QView. c2009. Available at https://home.qmpls.org/qview/ MainForm.aspx?dl=264201. Accessed October 6, 2010.
18. Cattaneo M, Lecchi A, Zighetti ML, et al. Platelet aggregation studies: autologous platelet-poor plasma inhibits platelet aggregation when added to platelet-rich plasma to normalize platelet count. Haematologica. 2007;92:694-697.
19. Mani H, Luxembourg B, Klaffling C, et al. Use of native or platelet count adjusted platelet rich plasma for platelet aggregation measurements. J Clin Pathol. 2005;58:747-750.
20. Linnemann B, Schwonberg J, Mani H, et al. Standardization of light transmittance aggregometry for monitoring antiplatelet therapy: an adjustment for platelet count is not necessary. J Thromb Haemost. 2008;6:677-683.
21. van der Stelt CA, van Werkum JW, Seesing TH, et al. To adjust or not to adjust the platelet count in light transmission aggregometry in patients receiving dual aspirin/clopidogrel treatment. Platelets. 2007;18:550-553.
22. Moffat KA, Hayward CP, Raby A. Quality Management Program-Laboratory Services. Hematology-Coagulation Broadsheet: Platelet Function Testing Performed by Light Transmittance Aggregometry [database on the Internet]. Toronto (ON). QMP-LS QView. c2009. Available at https:// home.qmpls.org/qview/MainForm.aspx? dl=291456. Accessed October 6, 2010.
23. Horn PS, Pesce AJ. Reference intervals: an update. Clin Chim Acta. 2003;334:5-23.
24. Federici AB, Mannucci PM, Castaman G, et al. Clinical and molecular predictors of thrombocytopenia and risk of bleeding in patients with von Willebrand disease type 2B: a cohort study of 67 patients. Blood. 2009;113:526-534.
25. Moffat KA, Ledford-Kraemer MR, Plumhoff EA, et al. Are laboratories following published recommendations for lupus anticoagulant testing? an international evaluation of practices. Thromb Haemost. 2009;101:178-184.
26. Hayward CP. Diagnostic approach to platelet function disorders. Transfus Apher Sci. 2008;38:65-76.